Medivir
在场
Medivir 是一家在股票代码 MVIR (SE) 下上市的公司。
高管
查看带有其 9 名主要高管的组织结构图
Medivir 搜索最多的简介
- Jens Lindberg, Chief Executive Officer
- Uli Hacksell, Chairman of the Board
- Lennart Hansson, Director
创建提醒
跟踪 Medivir 的高管变动
生物技术
Medivir 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Medivir 的最新新闻稿
- Press release
- Press release
- Press release
- Medivir to present at the Pareto Securities Healthcare Conference
- Medivir to present mature clinical data for fostrox + Lenvima at ESMO Conference and to host a webcast on September 16
- Medivir’s fostrox + Lenvima confirm promise of improved outcomes in advanced liver cancer, detailed and mature data presented at ESMO
- MEDIVIR AB – INTERIM REPORT JANUARY – JUNE 2024
- Medivir to present updated clinical data for fostrox + Lenvima in HCC at ESMO Conference in September
- Number of shares and votes in Medivir AB on 28 June 2024
- Fostrox + Lenvima® holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI
- View more press releases Close
通过电子邮件
